ArQule (ARQL)

ArQule Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARQL

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
14/02/2020	22:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
14/02/2020	17:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARQL	ArQule Inc
12/02/2020	22:03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
12/02/2020	17:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
10/02/2020	18:43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
05/02/2020	16:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
27/01/2020	18:55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ARQL	ArQule Inc
21/01/2020	11:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
21/01/2020	11:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
21/01/2020	11:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
06/01/2020	16:07	PR Newswire (US)	Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm	NASDAQ:ARQL	ArQule Inc
12/12/2019	20:49	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.	NASDAQ:ARQL	ArQule Inc
10/12/2019	08:02	Dow Jones News	Merck, Sanofi Push To Add Cancer Drugs -- WSJ	NASDAQ:ARQL	ArQule Inc
10/12/2019	00:16	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 4th Update	NASDAQ:ARQL	ArQule Inc
09/12/2019	21:37	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 3rd Update	NASDAQ:ARQL	ArQule Inc
09/12/2019	20:12	Dow Jones News	U.S. Stocks Slip as Trade War Weighs on Chinese Exports	NASDAQ:ARQL	ArQule Inc
09/12/2019	19:33	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 2nd Update	NASDAQ:ARQL	ArQule Inc
09/12/2019	16:13	Dow Jones News	Merck to Buy ArQule for $2.7 Billion -- Update	NASDAQ:ARQL	ArQule Inc
09/12/2019	13:05	Business Wire	ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...	NASDAQ:ARQL	ArQule Inc
09/12/2019	12:37	PR Newswire (US)	(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?	NASDAQ:ARQL	ArQule Inc
09/12/2019	12:26	Dow Jones News	Merck to Buy ArQule for $2.7 Billion, or $20/Share	NASDAQ:ARQL	ArQule Inc
09/12/2019	11:45	Business Wire	Merck to Acquire ArQule, Advancing Leadership in Oncology	NASDAQ:ARQL	ArQule Inc
25/11/2019	12:00	Business Wire	ArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...	NASDAQ:ARQL	ArQule Inc
13/11/2019	12:00	Business Wire	ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019	NASDAQ:ARQL	ArQule Inc
06/11/2019	14:05	Business Wire	ArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...	NASDAQ:ARQL	ArQule Inc
30/10/2019	14:57	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARQL	ArQule Inc
30/10/2019	11:30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARQL	ArQule Inc
30/10/2019	11:00	Business Wire	ArQule Reports Third Quarter 2019 Financial Results	NASDAQ:ARQL	ArQule Inc
29/10/2019	20:01	Business Wire	ArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...	NASDAQ:ARQL	ArQule Inc
21/10/2019	12:00	Business Wire	ArQule Announces Preclinical Data Demonstrating Potential of Miransertib (ARQ 092) to Treat PIK3CA-Driven Vascular Malformati...	NASDAQ:ARQL	ArQule Inc